Global State of Harm Reduction: 2025 Update to Key Data
The 2025 update summarises key developments in harm reduction services, funding and drug policy since the launch of the 9th edition of the report in November 2024. More
Calendar
Recent materials
Voices From the Frontline: How Global Funding Cuts Are Reshaping the Viral Hepatitis Response
In a commentary, published in The Lancet Gastroenterology & Hepatology, frontline voices reveal how recent global health funding cuts are already disrupting hepatitis B and C services worldwide. More
C-Free Study: Integrated Model of Care in Curing Hepatitis C in People Who Use Drugs in Thailand
The C-Free study concludes that community-based HCV treatment of people who use drugs in Thailand, within harm reduction settings, is safe and effective. More
‘Systemic Failure’: Global Reviews Show Extent of Injecting Drug Use and Infectious Diseases in Prisons
One in nine people in prisons globally have a history of injecting drug use and their risk of HIV, viral hepatitis and TB is up to 45 times higher than in the general population. More
Addressing Policy Barriers to Scaling up Needle and Syringe Programmes: A Global Call to Action
Scaling up needle and syringe programmes is essential for achieving global infectious disease-elimination goals and improving health outcomes among people who inject drugs. More
WHO Launches New Framework to Tackle Drug Resistance to HIV, Hepatitis B and C, and STIs
The Framework outlines a unified global approach to address drug resistance, a growing threat that risks undermining decades of progress toward ending AIDS and the epidemics of hepatitis B, hepatitis C, and STIs. More
